| Product Code: ETC7422316 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Guyana saw a significant increase in prostacyclin import shipments, with top exporters including the USA, Australia, India, Ireland, and the UK. Despite a high Herfindahl-Hirschman Index (HHI) indicating market concentration, the industry experienced a negative compound annual growth rate (CAGR) from 2020 to 2024. However, there was a remarkable growth spurt in 2024 with a growth rate of 103.24% compared to the previous year, suggesting potential opportunities for expansion and diversification in the prostacyclin market in Guyana.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Guyana Prostacyclin Market Overview |
3.1 Guyana Country Macro Economic Indicators |
3.2 Guyana Prostacyclin Market Revenues & Volume, 2021 & 2031F |
3.3 Guyana Prostacyclin Market - Industry Life Cycle |
3.4 Guyana Prostacyclin Market - Porter's Five Forces |
3.5 Guyana Prostacyclin Market Revenues & Volume Share, By Diseases, 2021 & 2031F |
3.6 Guyana Prostacyclin Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 Guyana Prostacyclin Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Guyana Prostacyclin Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.9 Guyana Prostacyclin Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Guyana Prostacyclin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Guyana Prostacyclin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pulmonary arterial hypertension in Guyana |
4.2.2 Growing awareness about prostacyclin therapy among healthcare professionals and patients |
4.2.3 Government initiatives to improve access to advanced healthcare treatments in the country |
4.3 Market Restraints |
4.3.1 High cost associated with prostacyclin therapy |
4.3.2 Limited availability of specialized healthcare facilities for the treatment of pulmonary arterial hypertension in Guyana |
5 Guyana Prostacyclin Market Trends |
6 Guyana Prostacyclin Market, By Types |
6.1 Guyana Prostacyclin Market, By Diseases |
6.1.1 Overview and Analysis |
6.1.2 Guyana Prostacyclin Market Revenues & Volume, By Diseases, 2021- 2031F |
6.1.3 Guyana Prostacyclin Market Revenues & Volume, By Pulmonary Arterial Hypertension, 2021- 2031F |
6.1.4 Guyana Prostacyclin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Guyana Prostacyclin Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Guyana Prostacyclin Market Revenues & Volume, By Epoprostenol, 2021- 2031F |
6.2.3 Guyana Prostacyclin Market Revenues & Volume, By Treprostinil, 2021- 2031F |
6.2.4 Guyana Prostacyclin Market Revenues & Volume, By Iloprost, 2021- 2031F |
6.3 Guyana Prostacyclin Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Guyana Prostacyclin Market Revenues & Volume, By Generic, 2021- 2031F |
6.3.3 Guyana Prostacyclin Market Revenues & Volume, By Branded, 2021- 2031F |
6.4 Guyana Prostacyclin Market, By Dosage |
6.4.1 Overview and Analysis |
6.4.2 Guyana Prostacyclin Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Guyana Prostacyclin Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Guyana Prostacyclin Market Revenues & Volume, By Inhalations, 2021- 2031F |
6.5 Guyana Prostacyclin Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Guyana Prostacyclin Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Guyana Prostacyclin Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Guyana Prostacyclin Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.6 Guyana Prostacyclin Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Guyana Prostacyclin Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.6.3 Guyana Prostacyclin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.4 Guyana Prostacyclin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.5 Guyana Prostacyclin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Guyana Prostacyclin Market Import-Export Trade Statistics |
7.1 Guyana Prostacyclin Market Export to Major Countries |
7.2 Guyana Prostacyclin Market Imports from Major Countries |
8 Guyana Prostacyclin Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in prostacyclin therapy |
8.2 Percentage increase in the number of patients receiving prostacyclin therapy |
8.3 Average waiting time for patients to access prostacyclin treatment in Guyana |
9 Guyana Prostacyclin Market - Opportunity Assessment |
9.1 Guyana Prostacyclin Market Opportunity Assessment, By Diseases, 2021 & 2031F |
9.2 Guyana Prostacyclin Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 Guyana Prostacyclin Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Guyana Prostacyclin Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.5 Guyana Prostacyclin Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Guyana Prostacyclin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Guyana Prostacyclin Market - Competitive Landscape |
10.1 Guyana Prostacyclin Market Revenue Share, By Companies, 2024 |
10.2 Guyana Prostacyclin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here